Generics 27

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tenoxicam manufacturers

27 products found

Filters

27 products found

tenoxicam

Tablets, film coated 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

tenoxicam

Solution for infusion 20 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Iraq , Latvia , Libya , Lithuania , Vietnam
Manufacturer #2346

Manufacturer usually replies in 7 days

tenoxicam

Vials, injection 20mg, 40mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

tenoxicam

Cutaneous gel 1%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 3 days

tenoxicam

Tablets, film coated 20mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16299
The company has a manufacturer’s license for medicinal products for human use authorized by the National Agency of Medicines. The highest quality products are manufactured and packaged in the production units with GMP International Standards and regularly checked by the National Agency of Medicines by the requirements of the European Medicines Agency (EMEA). The principal activity of the company is the production of pharmaceutical products, which are certified with patents, in various forms (tablets, capsules, syrups, oral solutions, powders for liquid compositions, gels, creams, and ointments) and various categories (antibiotics, antifungals, antivirals, anti-inflammatories, analgesics, antipyretics, anxiolytics, antidepressants, bronchodilators, antilipidemics, antitussives, cholinesterase inhibitors, antipsoriatics, antacids, anticholinergics, antidiarrheals, etc.).

Manufacturer usually replies in 15 days

tenoxicam

Capsules 20mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 11 days

tenoxicam

Vials, injection 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2272
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.

Manufacturer usually replies in 7 days

tenoxicam

Vials, injection 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

tenoxicam

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20656

Manufacturer usually replies in 2 days

tenoxicam

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20691

Manufacturer usually replies in 4 days

tenoxicam

Tablets, film coated 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

tenoxicam

Tablets 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Guatemala
GMP approvals
WHO
Manufacturer #17043
It is a pharmaceutical company founded in the 1990s, dedicated to the research and manufacture of high-quality medicines, with distribution at national, Central American, and Caribbean levels. It is considered one of the top ten pharmaceutical companies in Latin America, preferring consumers because of its high standards of quality, innovation, and service.

Manufacturer usually replies in 5 days

tenoxicam

Tablets 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Unavailable markets
Germany
Manufacturer #11630

Manufacturer usually replies in 4 days

tenoxicam

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

tenoxicam

Suppositories 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

tenoxicam

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

tenoxicam

Tablets, film coated 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #16472

Manufacturer usually replies in 7 days

tenoxicam

Tablets, film coated 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
Manufacturer #1403

Manufacturer usually replies in 8 days

tenoxicam

Capsules 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #13095

Manufacturer usually replies in 5 days

tenoxicam

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

Manufacturer usually replies in 12 days

Want to view all 27 products? Create your free account today!

Tenoxicam:

Tenoxicam, also known under the popular brand name Mobiflex, is a nonsteroidal anti-inflammatory medication used in the treatment of indications such as inflammation, swelling, stiffness, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and periarthritis of the shoulders or hips. It was originally patented by the pharmaceutical products manufacturing company Roche in 1974, following approval for medical sale on the marketplace in 1987.
Currently, it can be found for global sale and wholesale by many tenoxicam manufacturers and tenoxicam suppliers under other brand names including Tilatil, Tilcitin, and Alganex, along with other generic variations. This emerged genericness, driven by the expiration of the pharmaceutical products patent, has in large part accelerated its popularity. Making it both cost-effective and attractive for distributors to list for sale on the global marketplace. Where it can be found under numerous names and at various price points.

Method of action of tenoxicam:

Tenoxicam belongs to a group of medications termed nonsteroidal anti-inflammatory drugs, specifically it is within the oxicams class. This class binds closely to plasma proteins to carry out its effects. Although the exact mechanism of action for tenoxicam remains obscure, it is thought that it functions through the inhibition of cyclooxygenase by deactivation or irregulation of its underlying genes of COX-1 and COX-2. This subsequently causes peripheral inhibition of prostaglandin synthesis, which is necessary to sensitize pain receptors. Therefore, their inhibition accounts for the analgesic effects of tenoxicam. Additionally, antipyresis may occur through central action on the hypothalamus, resulting in peripheral dilation, increased blood flow, and heat loss.

Form and dosage of tenoxicam:

As with other drugs, the final form and packaging of tenoxicam is dependent on the manufacturers and suppliers, as well as the distributors and specific order. However, tenoxicam is typically listed for sale in different forms such as tablets, film-coated-tablets, solution for injection, and capsules. Tenoxicam is a prescription medication in most countries, such as the United Kingdom, but remains over the counter in others, such as the United States. Therefore, it is recommended that the local regulations be checked before attempting to acquire this product. Normal doses for the treatment of pain and inflammation in rheumatic disease and acute musculoskeletal disorders tend to be 20 mg once daily by mouth, or 20 mg once daily for 1–2 days through the intravenous injection or by intramuscular injection route. These values are however subject to change based on the manufacturers’ literature and professional medical advice.

Tenoxicam on Pipelinepharma:

Currently, we have found 9 trusted tenoxicam manufacturers and tenoxicam suppliers from our global list of online B2B wholesale sellers. These manufacturers and wholesale providers are located in various countries including the European Union, Egypt, Guatemala, and Bangladesh. Each company listed on our online B2B marketplace has been verified by the Pipelinepharma team according to strict quality control. This ensures the seriousness of each provider while reducing sourcing mileage, making for a hassle-free experience for all parties.

Price of tenoxicam and how to buy:

The cost of tenoxicam is highly dependent on numerous variables such as organisation, quantity, and market. Therefore, the price is subject to change, and an exact figure cannot be given. However, to aid in the sourcing process, manufacturers, suppliers, and distributors may choose to list their desired cost for their product on the online Pipelinepharma B2B marketplace. If indicated, an ‘Accept’ and ‘Negotiate’ button will appear next to the listing. In the absence of an indicated price, a ‘Get offer’ button will be displayed instead. This interface encourages a rapid transaction period, cutting down on overhead costs while increasing satisfaction for all parties.